{"entity":{"id":"nct01827605","kind":"trial","name":"A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)","aka":[],"tldr":"A phase 3 trial of Ibritumomab tiuxetan in Follicular lymphoma, run by Fondazione Italiana Linfomi - ETS, completed.","summary":"A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL) is a phase 3 interventional study registered as NCT01827605 by Fondazione Italiana Linfomi - ETS, with 159 participants recorded, started 2012-01 and reaching its primary completion in 2019-10. Interventions recorded: ZEVALIN, BEAM. Conditions recorded: Relapsed Follicular Lymphoma.\n\nLinked to the drug Ibritumomab tiuxetan because the registry names it among its interventions and Follicular lymphoma among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01827605","url":"https://clinicaltrials.gov/study/NCT01827605"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["follicular-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["ibritumomab-tiuxetan"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01827605","phase":"3","setting":"A Phase III Multicenter,Randomized Study Comparing Consolidation With 90yttrium-Labeled Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy Vs Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory Follicular Lymphoma (FL) Aged 18-65 Years","sponsor":"Fondazione Italiana Linfomi - ETS","enrolled":159,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01827605/","neighbours":{"cancer":[{"id":"follicular-lymphoma","kind":"cancer","name":"Follicular lymphoma","route":"/cancers/follicular-lymphoma/"}],"drug":[{"id":"ibritumomab-tiuxetan","kind":"drug","name":"Ibritumomab tiuxetan","route":"/drugs/ibritumomab-tiuxetan/"}]}}